Home > Healthcare > Medical Devices > Implantable Devices > Implantable Pacemakers Market

Implantable Pacemakers Market Share

Report ID: GMI9277
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Implantable Pacemakers Market Share

The implantable pacemakers industry is characterized by the presence of several established and emerging players that offer a variety of products and services across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.

Implantable Pacemakers Market Companies

Prominent players operating in the implantable pacemakers industry include:

Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Lepu Medical Technology
Medico S.R.L.
Medtronic plc
MicroPort Scientific Corporation
Shree Pacetronix Ltd.
Vitatron

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size for implantable pacemakers was valued at USD 5.7 billion in revenue in 2023 and is anticipated to grow at 4.6% CAGR from 2024 to 2032, driven by the increasing prevalence of cardiovascular diseases.

The bradycardia application segment in the implantable pacemakers industry reached USD 3.2 billion in 2023, owing to growing aging population, heart disease, medication side effects, and autonomic dysfunction.

North America market size was valued at USD 2.4 billion and is predicted to grow at 3.1% CAGR during 2024-2032, favored by technological innovations in the medical device industry.

Abbott Laboratories, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Lepu Medical Technology, Medico S.R.L., Medtronic plc., MicroPort Scientific Corporation, Shree Pacetronix Ltd. and Vitatron